Tibet Duo Rui Pharmaceutical Co., Ltd. (SHE:301075)
China
· Delayed Price · Currency is CNY 81.45
+0.74 (0.92%)
Apr 29, 2026, 4:00 PM EDT
SHE:301075 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2019 |
| Market Capitalization | 6,431 | 4,711 | 1,419 | 2,134 | 2,587 | 3,113 | Upgrade
|
| Market Cap Growth | 256.46% | 232.05% | -33.50% | -17.53% | -16.89% | - | Upgrade
|
| Enterprise Value | 6,645 | 5,025 | 1,303 | 1,851 | 2,116 | 2,503 | Upgrade
|
| Last Close Price | 81.45 | 59.67 | 17.97 | 26.49 | 32.12 | 37.76 | Upgrade
|
| PE Ratio | - | - | - | 113.18 | 126.19 | 45.44 | Upgrade
|
| PS Ratio | 41.71 | 30.56 | 5.90 | 6.38 | 6.45 | 5.88 | Upgrade
|
| PB Ratio | 10.31 | 7.56 | 1.88 | 2.60 | 3.43 | 3.95 | Upgrade
|
| P/TBV Ratio | 13.42 | 9.83 | 2.45 | 2.91 | 3.54 | 4.01 | Upgrade
|
| P/FCF Ratio | - | - | - | - | - | 72.72 | Upgrade
|
| P/OCF Ratio | - | - | - | 171.88 | 2296.41 | 64.65 | Upgrade
|
| EV/Sales Ratio | 43.10 | 32.59 | 5.42 | 5.54 | 5.28 | 4.72 | Upgrade
|
| EV/EBITDA Ratio | - | - | - | 117.47 | 128.68 | 32.90 | Upgrade
|
| EV/EBIT Ratio | - | - | - | - | 1167.41 | 40.12 | Upgrade
|
| EV/FCF Ratio | -45.01 | - | - | - | - | 58.47 | Upgrade
|
| Debt / Equity Ratio | 0.43 | 0.43 | 0.72 | 0.22 | 0.13 | 0.03 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | 11.02 | 5.76 | 0.27 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | - | 0.48 | Upgrade
|
| Net Debt / Equity Ratio | 0.27 | 0.27 | 0.18 | -0.37 | -0.54 | -0.75 | Upgrade
|
| Net Debt / EBITDA Ratio | -3.64 | -3.64 | -2.20 | -19.21 | -24.60 | -7.76 | Upgrade
|
| Net Debt / FCF Ratio | -1.12 | -1.12 | -1.25 | 26.85 | 12.80 | -13.79 | Upgrade
|
| Asset Turnover | 0.11 | 0.11 | 0.19 | 0.34 | 0.46 | 0.87 | Upgrade
|
| Inventory Turnover | 2.19 | 2.19 | 3.77 | 3.22 | 4.35 | 4.90 | Upgrade
|
| Quick Ratio | 0.48 | 0.48 | 1.04 | 4.49 | 4.19 | 11.36 | Upgrade
|
| Current Ratio | 0.74 | 0.74 | 1.24 | 5.02 | 4.48 | 11.61 | Upgrade
|
| Return on Equity (ROE) | -19.23% | -19.23% | -10.80% | 2.17% | 2.41% | 12.80% | Upgrade
|
| Return on Assets (ROA) | -4.19% | -4.19% | -4.21% | -0.16% | 0.13% | 6.38% | Upgrade
|
| Return on Invested Capital (ROIC) | -11.08% | -11.27% | -12.48% | -0.46% | 0.59% | 30.35% | Upgrade
|
| Return on Capital Employed (ROCE) | -11.20% | -11.20% | -8.60% | -0.30% | 0.20% | 7.90% | Upgrade
|
| Earnings Yield | -1.59% | -2.17% | -4.42% | 0.88% | 0.79% | 2.20% | Upgrade
|
| FCF Yield | -2.30% | -3.13% | -7.62% | -0.53% | -1.22% | 1.38% | Upgrade
|
| Dividend Yield | - | - | - | 0.47% | - | 1.65% | Upgrade
|
| Payout Ratio | - | - | - | 17.26% | 247.95% | 1.68% | Upgrade
|
| Buyback Yield / Dilution | -0.01% | 0.16% | -0.99% | 0.39% | -20.86% | -8.52% | Upgrade
|
| Total Shareholder Return | -0.01% | 0.16% | -0.99% | 0.86% | -20.86% | -6.87% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.